Table 2 Comparison of %ID/g as AUC, assuming at time = 0, 0% of the injected activity is in the tumor, of 125I-UU-40 and 125I-BIWA4 in ACT-1 xenografts, including 95% Confidence intervals (CI).

From: Selection, characterization and in vivo evaluation of novel CD44v6-targeting antibodies for targeted molecular radiotherapy

Antibody

125I-UU-40

125I-BIWA4

AUC (SD)

3093 (328.5)

1784 (152.1)

95% CI

2449–3737

1486–2083

  1. n ≥ 3 per time point and group.